JMP Securities Increases American Healthcare REIT (NYSE:AHR) Price Target to $18.00

American Healthcare REIT (NYSE:AHR) had its target price boosted by stock analysts at JMP Securities from $16.00 to $18.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “market outperform” rating on the stock. JMP Securities’ price target suggests a potential upside of 9.56% from the stock’s current price.

Separately, Truist Financial reaffirmed a “buy” rating and issued a $17.00 target price (up previously from $16.00) on shares of American Healthcare REIT in a research report on Monday, July 1st. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, American Healthcare REIT presently has a consensus rating of “Moderate Buy” and an average target price of $16.25.

American Healthcare REIT Stock Performance

NYSE:AHR traded down $0.24 during trading hours on Wednesday, reaching $16.43. 2,067,764 shares of the company were exchanged, compared to its average volume of 1,060,898. The company’s 50 day moving average is $15.41. American Healthcare REIT has a 52-week low of $12.63 and a 52-week high of $17.05. The company has a quick ratio of 0.33, a current ratio of 0.33 and a debt-to-equity ratio of 0.60.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.28). The firm had revenue of $504.60 million during the quarter, compared to analyst estimates of $506.55 million. American Healthcare REIT had a negative net margin of 2.77% and a negative return on equity of 3.26%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. Analysts expect that American Healthcare REIT will post 1.2 EPS for the current year.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, CEO Danny Prosky purchased 25,000 shares of the business’s stock in a transaction on Wednesday, May 22nd. The stock was bought at an average cost of $14.20 per share, with a total value of $355,000.00. Following the acquisition, the chief executive officer now owns 108,333 shares of the company’s stock, valued at $1,538,328.60. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Hedge Funds Weigh In On American Healthcare REIT

A number of hedge funds have recently modified their holdings of AHR. Principal Financial Group Inc. acquired a new stake in shares of American Healthcare REIT in the first quarter worth $88,504,000. Centersquare Investment Management LLC acquired a new position in shares of American Healthcare REIT in the 1st quarter valued at about $63,269,000. V3 Capital Management L.P. purchased a new stake in shares of American Healthcare REIT in the first quarter worth approximately $42,337,000. Goldentree Asset Management LP purchased a new position in American Healthcare REIT during the first quarter valued at approximately $22,125,000. Finally, Russell Investments Group Ltd. acquired a new position in American Healthcare REIT in the 1st quarter valued at approximately $20,381,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.